Four of five new drugs are awaiting approval by the FDA and hope to become blockbusters for their pharmaceutical drugmakers and inject new life into profits.
The drug is called denosumab, and it is used to stop the production of cells known as osteoclasts, that breakdown bone causing osteoporosis. Amgen is seeking approval for the new drug but the FDA is concerned the drug also supresses the immune system opening up someone to infections and cancer.
A federal court dismissed a lawsuit against Amgen Inc., alleging illegal promotion of two anemia drugs, Aranesp and Epogen, saying the case should have been made to regulators not federal court.
Amgen and Takeda, Japan’s largest pharmaceutical maker, have suspended enrollment in the last-stage trial of a key experimental cancer drug, after patients on the drug died more often than those taking placebo.
Customizing therapies to individual patients may require a pre-screening of a patient's genes, as researchers looking into targeted colon cancer therapies are reporting.
Two experimental osteoporosis drugs showed promise in clinical trials and increased bone mineral density in postmenopausal women with osteoporosis, according to researchers.
The Center for Public Integrity is reporting on the big bucks spent by Washington’s largest lobby – the pharmaceutical industry. In 2007- an all time new record was spent to lobby Congress - $168 million, a 32 percent jump over the previous year.
Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery. We are committed to serving the public with honesty and integrity in these efforts.
On the Road
Major Medical
Protecting Your Family
In the Workplace
Motley Rice Ranked A Best Law Firm by U.S. News and World Report
Tampa Toddler Dies After Being Left In Vehicle
Burn Advocates Network Returns From Mission In Haiti
Update: Burn Advocates Network In Haiti
Burn Advocates Network In Haiti